Search Results - "Taskinen MR"

Interaction of chylomicron remnants and VLDLs during ultracentrifuge separation based on the Svedberg flotation rate - Authors' response.

Authors: Björnson E Packard CJ Taskinen MR et al.

Source: Journal of internal medicine [J Intern Med] 2020 Jan; Vol. 287 (1), pp. 118. Date of Electronic Publication: 2019 Nov 12.

Publication Type: Letter; Comment

Journal Info: Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 8904841 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2796 (Electronic) Linking ISSN: 09546820 NLM ISO Abbreviation: J Intern Med Subsets: MEDLINE

Apolipoprotein C-III: Risk-factor, Regulator of Triglyceride-rich Lipoprotein Metabolism and Therapeutic Target.

Authors: Björnson E Adiels M Taskinen MR et al.

Source: Current atherosclerosis reports [Curr Atheroscler Rep] 2026 Feb 16; Vol. 28 (1), pp. 22. Date of Electronic Publication: 2026 Feb 16.

Publication Type: Journal Article; Review

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 100897685 Publication Model: Electronic Cited Medium: Internet ISSN: 1534-6242 (Electronic) Linking ISSN: 15233804 NLM ISO Abbreviation: Curr Atheroscler Rep Subsets: MEDLINE

Assessment of the Antidiabetic and Antihyperlipidemic activity of Solanum torvum Ethanolic Extract in HepG2 Cells.

Authors: Shakya, Ritika Anjana Male, CH. K. V. L. S. N.

Source: Bol Sustavy Pozvonochnik. 2026 Special Issue, Vol. 16, p164-170. 7p.

Mevalonic acid exerts procoagulant effect by potentiating factor Xa.

Authors: Niu, Liyuan Liu, Chuanfeng Wang, Shaoying et al.

Source: Natural Products & Bioprospecting. 1/10/2026, Vol. 16 Issue 1, p1-11. 11p.

Genetically determined increase in apolipoprotein C-III (APOC3 gain-of-function) delays very low-density lipoprotein clearance in humans.

Authors: Packard CJ Taskinen MR Björnson E et al.

Source: Atherosclerosis [Atherosclerosis] 2025 May; Vol. 404, pp. 119166. Date of Electronic Publication: 2025 Apr 05.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Elsevier Country of Publication: Ireland NLM ID: 0242543 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-1484 (Electronic) Linking ISSN: 00219150 NLM ISO Abbreviation: Atherosclerosis Subsets: MEDLINE

Effects of family history and sex on diabetes-related outcome in type 2 diabetes – Analysis from the tyrolean diabetes registry.

Authors: Plattner, Clemens Pfeifer, Bernhard Sourij, Harald et al.

Source: PLoS ONE. 6/18/2025, Vol. 20 Issue 6, p1-12. 12p.

Real-World Experience from Türkiye: Genetic and Therapeutic Insights in Pediatric Heterozygous Familial Hypercholesterolemia.

Authors: Yazıcı, Havva Er, Esra Erdem, Fehime et al.

Source: Journal of Clinical Research in Pediatric Endocrinology. 2026, Vol. 18 Issue 1, p74-84. 11p.

Dapagliflozin does not impair LDL catabolism and induces a shift towards a closer to normal VLDL1/VLDL2 catabolism in individuals with type 2 diabetes: a randomised in vivo kinetic study.

Authors: Vergès B Rouland A Bouillet B et al.

Source: Diabetologia [Diabetologia] 2026 Jul 17. Date of Electronic Publication: 2026 Jul 17.

Publication Type: Journal Article

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0006777 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0428 (Electronic) Linking ISSN: 0012186X NLM ISO Abbreviation: Diabetologia Subsets: MEDLINE

Meta-evolutionary exome analysis identifies novel type 2 diabetes mellitus genes in the UK Biobank and all of us.

Authors: Wilhelm, Kevin Asmussen, Jennifer Lee, Kwanghyuk et al.

Source: PLoS Genetics. 9/30/2025, Vol. 21 Issue 9, p1-28. 28p.

Identification of gene-sex hormone interactions associated with type 2 diabetes among men and women.

Authors: Dabbs-Brown, Amonae Liu, Chang Hui, Qin et al.

Source: PLoS Genetics. 9/2/2025, Vol. 21 Issue 9, p1-13. 13p.

From guidelines to practice: LDL-C achievement in very high cardiovascular risk patients – analysis of the EDHIPO MARCA registry.

Authors: Cordoba-Melo, Brayan Daniel Seni-Molina, Sebastián Arango-Ibanez, Juan Pablo et al.

Source: Lipids in Health & Disease. 9/2/2025, Vol. 24 Issue 1, p1-14. 14p.

Current perspectives on lipid management in diabetic kidney disease: Can fibrates offer advantages over statins for renal outcomes?

Authors: Chitsazi, Mohammad Reza Safari, Farzad Malekpour, Elena et al.

Source: Journal of Research in Medical Sciences. Jan2026, Vol. 31 Issue 1, p1-11. 11p.

Association Between Remnant Cholesterol and Endometriosis Findings from NHANES 1999–2006.

Authors: Su, Luyang Wang, Xiaona Zhang, Junqin et al.

Source: International Journal of Women's Health. Dec2025, Vol. 17, p5709-5718. 10p.

Genetic Association of Lipid-Lowering Drug Target Genes with Chronic Obstructive Pulmonary Disease: A Mendelian Randomization Study.

Authors: Luan, Hao Wang, Tianhua Wang, Rui et al.

Source: COPD: Journal of Chronic Obstructive Pulmonary Disease. Dec2025, Vol. 22 Issue 1, p1-10. 10p.

Associations of lipoprotein subclasses with all-cause and cardiovascular mortality: results of two independent cohorts with a 20 year follow-up.

Authors: Fierfas, Florian Bahls, Martin Henning, Ann-Kristin et al.

Source: Lipids in Health & Disease. 11/14/2025, Vol. 24 Issue 1, p1-12. 12p.

A six-year longitudinal study identifies a statin-independent association between low LDL-cholesterol and risk of type 2 diabetes.

Authors: Lembo, Maria Trimarco, Valentina Pacella, Daniela et al.

Source: Cardiovascular Diabetology. 11/11/2025, Vol. 24 Issue 1, p1-12. 12p.

Remnant cholesterol, low-density lipoprotein cholesterol and atherosclerotic cardiovascular disease in metabolic dysfunction-associated steatotic liver disease: a cohort study.

Authors: Zhou, Di Zhou, Mengge Chen, Shuohua et al.

Source: Lipids in Health & Disease. 11/4/2025, Vol. 24 Issue 1, p1-12. 12p.

The effects of non-insulin anti-diabetic medications on the diabetic microvascular complications: a systematic review and meta-analysis of randomized clinical trials.

Authors: Wen, Song Yuan, Yue Li, Yanyan et al.

Source: BMC Endocrine Disorders. 7/16/2025, Vol. 25 Issue 1, p1-23. 23p.

Synthesis, antioxidant, and antidiabetic potentials of (Z)-((dimethylcarbamothioyl) thio) ((1,1,1-trifluoro-4-oxo-4-phenylbut-2-en-2-yl) oxy) zinc hydrate.

Authors: Ogunlakin, Akingbolabo Daniel Olanrewaju, Adesoji Alani Ojo, Oluwafemi Adeleke et al.

Source: Comparative Clinical Pathology. Dec2024, Vol. 33 Issue 6, p949-959. 11p.

Quantifying Triglyceride-Rich Lipoprotein Atherogenicity, Associations With Inflammation, and Implications for Risk Assessment Using Non-HDL Cholesterol.

Authors: Björnson E Adiels M Gummesson A et al.

Source: Journal of the American College of Cardiology [J Am Coll Cardiol] 2024 Oct 01; Vol. 84 (14), pp. 1328-1338.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Biomedical Country of Publication: United States NLM ID: 8301365 Publication Model: Print Cited Medium: Internet ISSN: 1558-3597 (Electronic) Linking ISSN: 07351097 NLM ISO Abbreviation: J Am Coll Cardiol Subsets: MEDLINE